申请人:Imperial Chemical Industries PLC
公开号:US05270342A1
公开(公告)日:1993-12-14
The invention concerns novel N-phenylacetyl and related acyl derivatives of (4-amino-2,6-dimethylphenylsulphonyl)nitromethane and pharmaceutically acceptable salts thereof which are inhibitors of the enzyme aldose reductase and are of value, for example, in the treatment of certain peripheral effects of diabetes and galactosemia. Also disclosed are pharmaceutical compositions containing one of the derivatives and processes for the manufacture and use of the derivatives.
本发明涉及(4-氨基-2,6-二甲基苯磺酰)硝基甲烷的新型N-苯乙酰和相关酰衍生物及其药学上可接受的盐,它们是醛糖还原酶酶的抑制剂,在治疗糖尿病和半乳糖血症等某些周围效应方面具有价值。本发明还揭示了含有其中一种衍生物的制药组合物以及制造和使用这些衍生物的方法。